←Back to Expert Scholars
Translational Medicine / 转化医学Pancreatic Cancer Systemic Therapy
Kim A. Reiss
MD
🏢University of Pennsylvania Abramson Cancer Center🌐USA
Associate Professor of Medicine
40
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Dr. Kim Reiss investigates DNA damage response and PARP inhibitor strategies in pancreatic adenocarcinoma. She has led trials evaluating maintenance olaparib and rucaparib in BRCA and PALB2 altered disease. Her translational program integrates germline genetics with therapy selection.
Share:
🧪Research Fields 研究领域
pancreatic cancer
PARP inhibitors
BRCA
DNA damage response
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Kim A. Reiss 的研究动态
Follow Kim A. Reiss's research updates
留下邮箱，当我们发布与 Kim A. Reiss（University of Pennsylvania Abramson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment